secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protara Therapeutics, Inc. (TARA)
CIK:        0001359931
Form:       8-K
Filed at:   2025-12-08T23:59:59+00:00
Accession:  0001213900-25-119242
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protara Therapeutics prices public offering of 13M shares at $5.75 for $75M gross proceeds
--------------------------------------------------------------------------------

- Priced 13,043,479 common shares at $5.75 per share; gross proceeds ~$75M before fees.
- Underwriters granted 30-day option to buy up to 1,956,521 additional shares at same price.
- Net proceeds to fund clinical development of TARA-002 and other pipeline programs.
- Company and insiders subject to 60-day lock-up on share transfers post-offering.
- Offering closed Dec 8, 2025; J.P. Morgan, TD Securities, Piper Sandler acted as representatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1359931/000121390025119242/0001213900-25-119242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1359931/000121390025119242/ea0268756-8k_protara.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-119242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer